The report provides in-depth information on:
o Country Landscape This section covers information on the
prevailing economic environment in the country and dwells on both macro and
micro economic indicators. The demographic profile of the country highlights the
growing importance of middle class and increasing access to internet. It also
captures the political landscape along with the opportunities and challenges
presented by the country.
o Healthcare infrastructure Insightful review of the
countrys healthcare system and health status with key health indicators are
presented in this section. Moreover, healthcare expenditure and share of public
and private sectors are prominently discussed in the section. The profiles of
major hospitals and the number of healthcare personnel in the country are also
comprehensively covered
o Overview of Pharmaceutical Market This section depicts
the pharmaceutical market in terms of size, growth, product mix and key players
operating in the country. A special emphasis has been laid on the key drivers
and barriers impacting the pharmaceutical market of the country. Furthermore,
the profiles of major diseases with high burden for the country have been
covered
o Market Access: This section dwells on the role and
importance of various stakeholders in product commercialization process and
gatekeepers holding the key to the access for pharmaceutical products. Various
regulatory aspects crucial for approval and marketing of various categories of
pharmaceutical products have been captured comprehensively. In addition,
detailed analysis of pricing and reimbursement landscape along with the
prescribing policies and influence, price build-up and trends and various drug
lists impacting reimbursement is covere
Data-rich tables and figures have been used generously to
augment the report and assist the reader in better understanding of the subject
matter
Key questions answered in this report:
The report answers majority of key questions that are
paramount for the success of a pharmaceutical company such as:
How stable is the countrys political climate, major
economic indices like GDP size and growth, rate of inflation, FDI, etc.
impacting the level of business sentiments
How lucrative is the pharmaceutical market of the country
in terms of size, growth, product portfolio mix, key market segments and the
level of competitive intensity
Who are the relevant stakeholders that needs to be engaged
effectively for successful product commercialization
What are the key factors that influence the physician
prescribing habits and payer/hospital formulary decisions
What are the key trends and policies that may impact the
future market access landscape and how to effectively counter them
Which are the cost-containment measures that have been
adopted by the countrys government and may be introduced in the near future
Which are the major disease segments that a pharmaceutical
company can focus for product launch and growth based on the disease burden in
the country
What are the key policies that impacts the pricing and
reimbursement decisions in both public and private sector
Whether the countrys pharmaceutical market represents a
compelling commercial case to invest and offers significant opportunities that
can be successfully tapped resulting in significant revenue generation
Key benefits / Why should you buy this report:
As every countrys market access landscape is unique and
evolving, it makes a prudent decision to have a country specific market access
strategy. Moreover, the success of any pharmaceutical company hinges on
successfully navigating challenges posed by the various stakeholders and
regulatory bodies for effective product commercialization.
This report will serve as a handy tool for pharmaceutical
and other related healthcare stakeholders to
Understand the macro and micro parameters that will play a
pivotal role in making business decisions
Identify, segment, target and collaborate with the relevant
stakeholders that hold key to effective product commercialization
Conceptualize and formulate plausible market access
strategies based on the insights generated
Identify and foresee the major trends and policies likely
to impact the regulatory, pricing and reimbursement landscape of the country
Capitalize on the opportunities presented by the countrys
pharmaceutical market and mitigate the challenges posed by the competitors and
stakeholders/regulatory bodies
Generate market specific insights that are actionable and
commercially viable
Leverage market access insights by incorporating physicians
and payer priorities so as to develop effective sales and marketing strategies
resulting in increased brand and company revenue
Correctly ascertain the appropriate market access levers
and barriers that will drive or hamper the brand performance
Prioritize and assign optimal resources required for
implementation of various market access activities
You can order
full Report @
Contact
Details:
Aarkstore Enterprise
Phone:
+91 998 729 5242 / +91 - 22 2756 4953
Email: enquiry@aarkstore.com
Our Website: http://www.aarkstore.com
Our Blog : http://www.aarkstore.com/blog/
Our News Section : http://www.aarkstore.com/news
Email: enquiry@aarkstore.com
Our Website: http://www.aarkstore.com
Our Blog : http://www.aarkstore.com/blog/
Our News Section : http://www.aarkstore.com/news
No comments:
Post a Comment